These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20660958)

  • 1. New challenges for laboratory diagnostics in non-small cell lung cancer.
    Holdenrieder S; Stieber P
    Cancer Biomark; 2010; 6(3-4):119-21. PubMed ID: 20660958
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer procoagulant (CP) in lung cancer.
    Rucińska M; Skrzydlewski Z; Zaremba E; Furman M; Kasacka I
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():251-3. PubMed ID: 9337542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor expression in nonsmall cell lung cancer: histopathologic and clinical correlates.
    Carbognani P; Rusca M; Romani A; Spaggiari L; Cattelani L; Solli P; Bobbio P
    Cancer; 1996 Jul; 78(1):178-9. PubMed ID: 8646716
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Markers in lung cancer].
    Balibrea JL
    An R Acad Nac Med (Madr); 1993; 110(4):585-603; discussion 604-5. PubMed ID: 8048751
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of lung cancer in silicosis patients using a tumor-marker panel.
    Schneider J
    Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small-cell lung cancer: then and now.
    Schiller JH; Gandara DR; Goss GD; Vokes EE
    J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
    [No Abstract]   [Full Text] [Related]  

  • 8. Arginase and ornithine, as markers in human non-small cell lung carcinoma.
    Süer Gökmen S; Yörük Y; Cakir E; Yorulmaz F; Gülen S
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):125-31. PubMed ID: 10738908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-2 protein in non-small-cell lung carcinoma.
    Katz HR
    N Engl J Med; 1994 Jan; 330(3):221. PubMed ID: 8264763
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular staging and the selection of therapy for non-small cell lung cancer.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
    Gazdar AF; Mulshine JL; Kramer BS
    Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
    Brockmöller J; Junker K; Multhoff G
    Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells.
    Zhao Z; Xu L; Shi X; Tan W; Fang X; Shangguan D
    Analyst; 2009 Sep; 134(9):1808-14. PubMed ID: 19684903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
    Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
    J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.